Advanced
Product
Solutions
Partners
Resources
Company
Toggle menu
Home
/
Western Oncolytics
Western Oncolytics
Overview
Locations
Financials
Operating Metrics
Human Capital
Key People
Competitors
Supplier Risk
Western Oncolytics
Total Funding
$2.8 M
Western Oncolytics Summary
Company Summary
Overview
Western Oncolytics is a company providing oncolytic immunotherapies to cancer patients. It engineers a vaccinia virus-based oncolytic platform, which can be combined with multiple transgenes to create versatile and differentiated immunotherapies.
Type
Private
Status
Closed
Founded
2014
HQ
Pittsburgh, PA, US
|
view all locations
Website
https://westernoncolytics.com
Cybersecurity rating
Sectors
Healthcare
bioengineering
biotech
oncology
platform
Homepage
Linkedin
twitter
Table of Contents
Key People
Locations
Competitors
Key People
Helena Chaye,
CEO
Stephen H. Thorne,
Chief Scientific Officer and Director
Kurt Rote,
Director
Tom Leonard,
Director
and 1 others
Locations
View all
1 location detected
Pittsburgh, PA
HQ
United States
240 Alpha Dr
Competitors and Similar Companies
Crescendo Biologics
Healthcare - Private
Bioptamers
Healthcare - Private
Smartox Biotechnology
Healthcare - Private
Walking Fish Therapeutics
Healthcare - Private
Compare competitors
Footer menu
Contact us
Product
Intelligence Suite
Supplier Intelligence Platform
Craft Intelligence Portal
Craft API
Craft for Teams
Supplier Intelligence Platform
Craft Alerts
Craft N-Tier Mapping
Craft Risk Hub
Chrome extension
Solutions
Supplier Intelligence
Sales Intelligence
Aerospace and Defense
Resources
Resource center
Blog
Company
About
Careers
Contact
Terms of Service
Privacy Policy
Security
© Craft.co 2026
Share price data provided by IEX
Back
to top